KLEA HOLDING
Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. The company was formerly known as Visiom… Read more
KLEA HOLDING (ALKLH) - Net Assets
Latest net assets as of December 2024: €27.82 Million EUR
Based on the latest financial reports, KLEA HOLDING (ALKLH) has net assets worth €27.82 Million EUR as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€37.83 Million) and total liabilities (€10.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €27.82 Million |
| % of Total Assets | 73.56% |
| Annual Growth Rate | 15.55% |
| 5-Year Change | N/A |
| 10-Year Change | 132.07% |
| Growth Volatility | 431.5 |
KLEA HOLDING - Net Assets Trend (2010–2024)
This chart illustrates how KLEA HOLDING's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for KLEA HOLDING (2010–2024)
The table below shows the annual net assets of KLEA HOLDING from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €27.82 Million | +12.42% |
| 2023-12-31 | €24.75 Million | +1.97% |
| 2022-12-31 | €24.27 Million | +72.45% |
| 2021-12-31 | €14.07 Million | +419.09% |
| 2020-12-31 | €-4.41 Million | +13.75% |
| 2019-12-31 | €-5.11 Million | -1516.62% |
| 2018-12-31 | €361.00K | -97.15% |
| 2017-12-31 | €12.66 Million | +55.36% |
| 2016-12-31 | €8.15 Million | -32.02% |
| 2015-12-31 | €11.99 Million | +172.48% |
| 2014-12-31 | €4.40 Million | -16.54% |
| 2013-12-31 | €5.27 Million | -14.79% |
| 2012-12-31 | €6.19 Million | -26.51% |
| 2011-12-31 | €8.42 Million | +128.95% |
| 2010-12-31 | €3.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to KLEA HOLDING's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 354687500.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.41 Million | 5.03% |
| Common Stock | €3.08 Million | 11.00% |
| Other Components | €23.47 Million | 83.97% |
| Total Equity | €27.95 Million | 100.00% |
KLEA HOLDING Competitors by Market Cap
The table below lists competitors of KLEA HOLDING ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lokotech Group AS
OL:LOKO
|
$33.57 Million |
|
Safety Shot Inc
NASDAQ:SHOT
|
$33.57 Million |
|
ActRO Co. Ltd
KQ:290740
|
$33.57 Million |
|
Penguen Gida Sanayi AS
IS:PENGD
|
$33.57 Million |
|
Pixelworks Inc
NASDAQ:PXLW
|
$33.55 Million |
|
Semen Baturaja Persero Tbk
JK:SMBR
|
$33.55 Million |
|
Dae Young Pkg
KO:014160
|
$33.54 Million |
|
Perdana Karya Perkasa Tbk
JK:PKPK
|
$33.53 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in KLEA HOLDING's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 24,102,000 to 27,951,000, a change of 3,849,000 (16.0%).
- Net income of 1,405,000 contributed positively to equity growth.
- Other factors increased equity by 2,444,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €1.41 Million | +5.03% |
| Other Changes | €2.44 Million | +8.74% |
| Total Change | €- | 15.97% |
Book Value vs Market Value Analysis
This analysis compares KLEA HOLDING's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.85x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.01x to 1.85x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | €30.16 | €0.18 | x |
| 2011-12-31 | €96.04 | €0.18 | x |
| 2012-12-31 | €56.87 | €0.18 | x |
| 2013-12-31 | €34.76 | €0.18 | x |
| 2014-12-31 | €23.06 | €0.18 | x |
| 2015-12-31 | €29.49 | €0.18 | x |
| 2016-12-31 | €16.40 | €0.18 | x |
| 2017-12-31 | €10.67 | €0.18 | x |
| 2018-12-31 | €0.20 | €0.18 | x |
| 2019-12-31 | €-0.36 | €0.18 | x |
| 2020-12-31 | €-0.17 | €0.18 | x |
| 2021-12-31 | €0.10 | €0.18 | x |
| 2022-12-31 | €0.09 | €0.18 | x |
| 2023-12-31 | €0.07 | €0.18 | x |
| 2024-12-31 | €0.09 | €0.18 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently KLEA HOLDING utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.03%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.14%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 1.35x
- Recent ROE (5.03%) is above the historical average (-406.16%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | -56.23% | -20.10% | 0.78x | 3.57x | €-2.44 Million |
| 2011 | -27.35% | -18.35% | 0.81x | 1.83x | €-3.14 Million |
| 2012 | -45.35% | -20.43% | 1.06x | 2.09x | €-3.42 Million |
| 2013 | -49.47% | -23.14% | 0.89x | 2.39x | €-3.14 Million |
| 2014 | -59.04% | -19.52% | 0.89x | 3.41x | €-3.04 Million |
| 2015 | -60.74% | -66.86% | 0.57x | 1.61x | €-8.48 Million |
| 2016 | -164.57% | -141.32% | 0.49x | 2.38x | €-14.23 Million |
| 2017 | -103.89% | -125.79% | 0.52x | 1.59x | €-14.42 Million |
| 2018 | -5481.16% | -226.45% | 0.47x | 51.32x | €-19.82 Million |
| 2019 | 0.00% | -234.96% | 0.69x | 0.00x | €-23.54 Million |
| 2020 | 0.00% | -27.14% | 3.21x | 0.00x | €-4.71 Million |
| 2021 | -31.67% | -62.14% | 0.16x | 3.13x | €-5.86 Million |
| 2022 | -21.74% | -36.53% | 0.40x | 1.49x | €-7.70 Million |
| 2023 | 3.74% | 6.58% | 0.37x | 1.52x | €-1.51 Million |
| 2024 | 5.03% | 8.14% | 0.46x | 1.35x | €-1.39 Million |
Industry Comparison
This section compares KLEA HOLDING's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $13,754,488
- Average return on equity (ROE) among peers: -8.17%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| KLEA HOLDING (ALKLH) | €27.82 Million | -56.23% | 0.36x | $33.56 Million |
| Eurofins-Cerep SA (ALECR) | $25.16 Million | 15.33% | 0.40x | $93.20 Million |
| Predilife (ALPRE) | $-764.29K | 0.00% | 0.00x | $3.26 Million |
| Lumibird SA (LBIRD) | $16.86 Million | -39.85% | 2.25x | $227.06 Million |